MRNA News
Moderna, Inc.
$248.69
-$2.14(-0.85%)
61
Overall
60
Value
66
Tech
57
Quality
Market Cap
$100.63B
Volume
7.55M
52W Range
$22.28 - $267.50
Target Price
$140.05
MRNA news: the latest Moderna, Inc. headlines, press releases and market updates, newest first.
Latest MRNA News
- Moderna (MRNA) Receives a Hold from UBSTipRanks Auto-Generated Intelligence Newsdesk · Nov 9, 2026
- Moderna Stock Faces Dilution Risk and Downward Pressure From Convertible Note ConversionsTipRanks Auto-Generated Newsdesk · Nov 8, 2026
- Polymarket Odds: Will MRNA, HUM, UAA Beat Earnings Tomorrow?Eddie Pan · Nov 5, 2026
- Moderna Advances Testing of Updated COVID-19 Vaccines as Investors Await ResultsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 4, 2026
- Moderna Updates Early-Stage EBV Vaccine Study: What MRNA Investors Should WatchTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 4, 2026
- The Week That Was, The Week Ahead: Macro and Markets, November 1Ran Melamed · Nov 1, 2026
- Moderna’s Next‑Gen Pediatric Covid Shot Enters Key Phase 2 Test: What Investors Should WatchTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 29, 2026
- Moderna’s Next Flu Move: New Pediatric mRNA-1010 Trial Targets Long-Term Vaccine GrowthTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 28, 2026
- RBC Capital Sticks to Their Hold Rating for Moderna (MRNA)TipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Moderna (MRNA) Receives a Hold from Evercore ISITipRanks Auto-Generated Intelligence Newsdesk · Oct 26, 2026
- Moderna’s Cancer Vaccine Earns Praise from Doctors amid Stock SelloffVince Condarcuri · Oct 23, 2026
- Moderna’s Norovirus Vaccine Trial Reaches Key Milestone, Supporting Its Post-COVID Growth StoryTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 23, 2026
- Moderna Stock Is Crashing Over 20%: What Spooked Investors and What Wall Street Sees NextBen Yoffe · Oct 22, 2026
- Moderna Stock (MRNA) Plunges 25% as Data Is Leaked OnlineJoel Baglole · Oct 22, 2026
- Analysts Conflicted on These Healthcare Names: Elevance Health (ELV), Moderna (MRNA) and Abbott Laboratories (ABT)TipRanks Newsroom · Oct 22, 2026
- RBC Capital Remains a Hold on Moderna (MRNA)TipRanks Auto-Generated Intelligence Newsdesk · Oct 17, 2026
- RBC Capital Remains a Hold on Moderna (MRNA)TipRanks Auto-Generated Intelligence Newsdesk · Oct 17, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MRNA | $248.69 | -0.9% | 7.55M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |